Competitive advantage of PET/MRI

European Journal of Radiology - Tập 83 Số 1 - Trang 84-94 - 2014
Hossein Jadvar1, Patrick M. Colletti1
1Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Gambhir, 2002, Molecular imaging of cancer with positron emission tomography, Nature Reviews. Cancer, 2, 683, 10.1038/nrc882

Basu, 2008, Unparalleled contribution of 18F-FDG PET to medicine over 3 decades, Journal of Nuclear Medicine, 49

Shao, 1997, Simultaneous PET and MR imaging, Physics in Medicine and Biology, 42, 1965, 10.1088/0031-9155/42/10/010

Tatsumi, 2013, Simultaneous PET/MRI body imaging in rats: initial experiences with an integrated PET/MRI scanner, Annals of Nuclear Medicine, 27, 225

Judenhofer, 2008, Simultaneous PET-MRI: a new approach for functional and morphological imaging, Nature Medicine, 14, 459, 10.1038/nm1700

Wehrl, 2009, Preclinical PET/MR: technological advances and new perspectives in biomedical research, European Journal of Nuclear Medicine and Molecular Imaging, 36, S56, 10.1007/s00259-009-1078-0

Gaertner, 2013, PET/MR: a paradigm shift, Cancer Imaging, 13, 36, 10.1102/1470-7330.2013.0005

Pichler, 2008, Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?, Seminars in Nuclear Medicine, 38, 199, 10.1053/j.semnuclmed.2008.02.001

Pichler, 2010, PET/MRI: paving the way for the next generation of clinical multimodality imaging applications, Journal of Nuclear Medicine, 51, 333, 10.2967/jnumed.109.061853

Sauter, 2010, Combined PET/MRI: one step further in multimodality imaging, Trends in Molecular Medicine, 16, 508, 10.1016/j.molmed.2010.08.003

von Schulthess, 2009, A look ahead: PET/MRI versus PET/CT, European Journal of Nuclear Medicine and Molecular Imaging, 36, S3, 10.1007/s00259-008-0940-9

Werner, 2012, MR/PET: a new challenge in hybrid imaging, AJR. American Journal of Roentgenology, 199, 272, 10.2214/AJR.12.8724

Schiepers, 2011, Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging, European Radiology, 21, 548, 10.1007/s00330-010-2033-y

Schlemmer, 2008, Simultaneous MR/PET imaging of the human brain: feasibility study, Radiology, 248, 1028, 10.1148/radiol.2483071927

Torigian, 2013, PET/MR imaging: technical aspects and potential clinical applications, Radiology, 267, 26, 10.1148/radiol.13121038

Veit-Haibarch, 2013, PET/MR imaging using a tri-modality PET/CT/MR system with a dedicated shuttle in clinical routine, Magma (New York, N.Y.), 26, 25

Zaidi, 2011, Design and performance evaluation of a whole-body Ingenuity TF PET/MRI system, Physics in Medicine and Biology, 56, 3091, 10.1088/0031-9155/56/10/013

Kalemis, 2013, Sequential whole-body PET/MR scanner: concept, clinical use, and optimization after two years in the clinic. The manufacturer's perspective, Magma (New York, N.Y.), 26, 5

Drzezga, 2012, First clinical experience of integrated whole-body PET/MR: comparison to PET/CT in patients with oncological diagnoses, Journal of Nuclear Medicine, 53, 845, 10.2967/jnumed.111.098608

Zaidi, 2011, An outlook on future design of hybrid PET/MRI systems, Medical Physics, 38, 3689, 10.1118/1.3633909

Delso, 2011, Performance measurement of the Siemens mMR integrated whole-body PET/MR scanner, Journal of Nuclear Medicine, 52, 1914, 10.2967/jnumed.111.092726

Hofmann, 2009, Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques, European Journal of Nuclear Medicine and Molecular Imaging, 36, S93, 10.1007/s00259-008-1007-7

Kim, 2012, Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data, Journal of Nuclear Medicine, 53, 1878, 10.2967/jnumed.112.104109

Keller, 2013, Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI, Magma (New York, N.Y.), 26, 173

Martinez-Moller, 2009, Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data, Journal of Nuclear Medicine, 50, 520, 10.2967/jnumed.108.054726

Martinez-Moller, 2012, Attenuation correction for PET/MR: problems, novel approaches and practical solutions, Zeitschrift fur Medizinische Physik, 22, 299, 10.1016/j.zemedi.2012.08.003

Keereman, 2012, Challenges and current methods for attenuation correction in PET/MR, Magma (New York, N.Y.), 26, 81

Yankeelov, 2012, Simultaneous PET-MRI in oncology: a solution looking for a problem, Magnetic Resonance Imaging, 30, 1342, 10.1016/j.mri.2012.06.001

Brix, 2009, Risks and safety aspects related to PET/MR examination, European Journal of Nuclear Medicine and Molecular Imaging, 36, S131, 10.1007/s00259-008-0937-4

Sattler, 2012, Physical and organizational provision for installation, regulatory requirement and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting, Magma (New York, N.Y.), 26, 159

Chun, 2012, MRI-based nonrigid motion correction in simultaneous PET/MRI, Journal of Nuclear Medicine, 53, 1284, 10.2967/jnumed.111.092353

Glaus, 2010, In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agents, Bioconjugate Chemistry, 21, 715, 10.1021/bc900511j

Martinez-Moller, 2012, Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology, Journal of Nuclear Medicine, 53, 1415, 10.2967/jnumed.112.109348

von Schulthess, 2013, Clinical positron emission tomography/magnetic resonance imaging applications, Seminars in Nuclear Medicine, 43, 3, 10.1053/j.semnuclmed.2012.08.005

von Schulthess, 2010, Integrating imaging modalities: what makes sense from workflow perspective?, European Journal of Nuclear Medicine and Molecular Imaging, 37, 980, 10.1007/s00259-009-1378-4

Vargas, 2013, Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies, Magma (New York, N.Y.), 26, 57

Lois, 2012, Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging, European Journal of Nuclear Medicine and Molecular Imaging, 39, 1756, 10.1007/s00259-012-2190-0

Wiesmuller, 2013, Comparison of lesion detection and quantitation of racer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT, European Journal of Nuclear Medicine and Molecular Imaging, 40, 12, 10.1007/s00259-012-2249-y

Catana, 2012, PET/MRI for neurologic applications, Journal of Nuclear Medicine, 53, 1916, 10.2967/jnumed.112.105346

Yang, 2012, Brain amyloid imaging – FDA approval of florbetapir F18 injection, The New England Journal of Medicine, 367, 885, 10.1056/NEJMp1208061

Cho, 2013, In-vivo human brain molecular imaging with a brain-dedicated PET/MRI, Magma (New York, N.Y.), 26, 71

Cho, 2011, Observation of glucose metabolism in the thalamic nuclei by fusion PET/MRI, Journal of Nuclear Medicine, 52, 401, 10.2967/jnumed.110.081281

Cho, 2010, Substructural hippocampal glucose metabolism observed on PET/MRI, Journal of Nuclear Medicine, 51, 1545, 10.2967/jnumed.110.076182

Chua, 2008, Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review, Current Opinion in Neurology, 21, 83, 10.1097/WCO.0b013e3282f4594b

Dickerson, 2008, Functional abnormalities of the medial temporal memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies, Neuropsychologia, 46, 1624, 10.1016/j.neuropsychologia.2007.11.030

Greicius, 2004, Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI, Proceedings of the National Academy of Sciences of the United States of America, 101, 4637, 10.1073/pnas.0308627101

Heiss, 2009, The potential of PET/MR for brain imaging, European Journal of Nuclear Medicine and Molecular Imaging, 36, S105, 10.1007/s00259-008-0962-3

Boss, 2010, Diffusion tensor imaging in a human PET/MR hybrid system, Investigative Radiology, 45, 270, 10.1097/RLI.0b013e3181dc3671

Garibotto, 2013, Clinical applications of hybrid PET/MRI in neuroimaging, Clinical Nuclear Medicine, 38, e13, 10.1097/RLU.0b013e3182638ea6

Rischpler, 2013, Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects, Journal of Nuclear Medicine, 54, 402, 10.2967/jnumed.112.105353

Lee, 2012, PET/MRI of inflammation in myocardial infarction, Journal of the American College of Cardiology, 59, 153, 10.1016/j.jacc.2011.08.066

Buchbender, 2012, Oncologic PET/MRI. Part 1. Tumors of the brain, head and neck, chest, abdomen, and pelvis, Journal of Nuclear Medicine, 53, 928, 10.2967/jnumed.112.105338

Buchbender, 2012, Oncologic PET/MRI. Part 2. Bone tumors, soft-tissue tumors, melanoma, and lymphoma, Journal of Nuclear Medicine, 53, 1244, 10.2967/jnumed.112.109306

Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, The New England Journal of Medicine, 348, 2491, 10.1056/NEJMoa022749

Kjaer, 2013, PET/MRI in cancer patients: first experiences and vision from Copenhagen, Magma (New York, N.Y.), 26, 37

Quick, 2013, Integrated whole-body PET/MR hybrid imaging: clinical experience, Investigative Radiology, 48, 280, 10.1097/RLI.0b013e3182845a08

Schwenzer, 2012, Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients-current state of imaging quality, European Journal of Radiology, 81, 3472, 10.1016/j.ejrad.2011.12.027

Boss, 2010, Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT, Journal of Nuclear Medicine, 51, 1198, 10.2967/jnumed.110.074773

Thorwarth, 2011, Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience, International Journal of Radiation Oncology, Biology, Physics, 81, 277, 10.1016/j.ijrobp.2010.10.078

Blodgett, 2005, Combined PET-CT in the head and neck. Part 1. Physiologic, altered physiologic, and artifactual FDG uptake, Radiographics, 25, 897, 10.1148/rg.254035156

Fukui, 2005, Combined PET-CT in the head and neck. Part 2. Diagnostic uses and pitfalls of oncologic imaging, Radiographics, 25, 913, 10.1148/rg.254045136

Boss, 2011, Feasibility of simultaneous PET/MR imaging in the head and upper neck area, European Radiology, 21, 1439, 10.1007/s00330-011-2072-z

Platzek, 2013, PET/MRI in head and neck cancer: initial experience, European Journal of Nuclear Medicine and Molecular Imaging, 40, 6, 10.1007/s00259-012-2248-z

Antoch, 2009, Combined PET/MRI: a new dimension in whole-body oncologic imaging?, European Journal of Nuclear Medicine and Molecular Imaging, 36, S113, 10.1007/s00259-008-0951-6

Antoch, 2003, Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology, Journal of the American Medical Association, 290, 3199, 10.1001/jama.290.24.3199

Schmidt, 2013, Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F]fluoro-2-d-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system, Investigative Radiology, 48, 247, 10.1097/RLI.0b013e31828d56a1

Shamim, 2008, PET, PET/CT, and PET/MRI assessment of breast cancer, PET Clinics, 3, 81

Aklan, 2013, Toward simultaneous PET/MR breast imaging: systematic evaluation and integration of a radiofrequency breast coil, Medical Physics, 40, 024301, 10.1118/1.4788642

Schwenzer, 2012, Whole-body MR/PET: applications in abdominal imaging, Abdominal Imaging, 37, 20, 10.1007/s00261-011-9809-7

Schlemmer, 2009, An integrated MR/PET system: prospective applications, Abdominal Imaging, 34, 668, 10.1007/s00261-008-9450-2

Di Martino, 2010, Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis, Radiology, 256, 806, 10.1148/radiol.10091334

Jadvar, 2012, Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers, Seminars in Nuclear Medicine, 42, 247, 10.1053/j.semnuclmed.2012.02.001

Yong, 2011, Sensitivity of PET/MRI images in liver metsatses from colorectal carcinoma, Hellenic Journal of Nuclear Medicine, 14, 264

Beiderwellen, 2013, Simultaneous 68Ga-DOTADOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results, Investigative Radiology, 48, 273, 10.1097/RLI.0b013e3182871a7f

Wu, 2012, The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis, AJR. American Journal of Roentgenology, 199, 103, 10.2214/AJR.11.7634

Park, 2012, Introducing parametric fusion PET/MRI of primary prostate cancer, Journal of Nuclear Medicine, 53, 546, 10.2967/jnumed.111.091421

Jadvar, 2012, Molecular Imaging of prostate cancer: PET radiotracers, AJR. American Journal of Roentgenology, 199, 278, 10.2214/AJR.12.8816

Wetter, 2013, Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results, Investigative Radiology, 48, 256, 10.1097/RLI.0b013e318282c654

Kim, 2008, Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients, European Journal of Cancer, 45, 2103, 10.1016/j.ejca.2009.04.006

Fiaschetti, 2011, MR-PET fusion imaging in evaluating adnexal lesions: a preliminary study, La Radiologia Medica, 116, 1288, 10.1007/s11547-011-0720-7

Nakajo, 2010, Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography, Japanese Journal of Radiology, 28, 95, 10.1007/s11604-009-0387-3

Vargas, 2013, Peripheral nerves, tumors, and hybrid PET-MRI, Clinical Nuclear Medicine, 38, e40, 10.1097/RLU.0b013e31824c6013

Punwani, 2013, Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?, European Journal of Nuclear Medicine and Molecular Imaging, 40, 373, 10.1007/s00259-012-2293-7

Tewfik, 2008, Fluorine-18-deoxyglucose positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay, Current Problems in Diagnostic Radiology, 37, 178, 10.1067/j.cpradiol.2007.10.005

Schmidt, 2007, Whole-body magnetic resonance and positron emission tomography-computed tomography in oncology, Topics in Magnetic Resonance Imaging, 18, 193, 10.1097/RMR.0b013e318093e6bo

Wu, 2011, No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study, European Journal of Radiology, 79, e117, 10.1016/j.ejrad.2011.04.062

Rahmouni, 2005, MRI and PET in monitoring response in lymphoma, Cancer Imaging, 5, S106, 10.1102/1470-7330.2005.0038

Laurent, 2012, Compartaive study of tow whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET/CT, European Journal of Radiology, 22, 1537

Chen, 2008, Evaluation of musculoskeletal disorders with PET, PET/CT, and PET/MRI, PET Clinics, 3, 451, 10.1016/j.cpet.2009.03.003

Basu, 2007, Potential role of FDG PET in the setting of diabetic neuroosteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft tissue infection?, Nuclear Medicine Communications, 28, 465, 10.1097/MNM.0b013e328174447f

Nawaz, 2010, Diagnostic performance of FDG PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomeylitis in the diabetic foot, Molecular Imaging and Biology, 12, 335, 10.1007/s11307-009-0268-2

Miese, 2011, Hybrid 18F-FDG PET-MRI of the hand in rheumatoid arthritis: initial results, Clinical Rheumatology, 30, 1247, 10.1007/s10067-011-1777-3

Glaudemans, 2012, PET/MRI in infectious and inflammatory diseases: will it be a useful improvement, European Journal of Nuclear Medicine and Molecular Imaging, 39, 745, 10.1007/s00259-012-2060-9

Maccioni, 2012, New frontiers of MRI in Crohn's disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI), Abdominal Imaging, 37, 974, 10.1007/s00261-012-9890-6

Salamon, 2008, FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy, Neurology, 71, 1594, 10.1212/01.wnl.0000334752.41807.2f

Rubí, 2011, Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy, Epilepsia, 52, 2216, 10.1111/j.1528-1167.2011.03295.x

Jissendi-Tchofo, 2012, Brain regional glucose uptake changes in isolated cerebellar cortical dysplasia: qualitative assessment using coregistrated FDG-PET/MRI, Cerebellum, 11, 280, 10.1007/s12311-011-0309-7

Pfluger, 2012, Diagnostic value of combined (18)F-FDG PET/MRI for staging and restaging in pediatric oncology, European Journal of Nuclear Medicine and Molecular Imaging, 39, 1745, 10.1007/s00259-012-2228-3

Fahey, 2011, Minimizing and communicating radiation risk in pediatric nuclear medicine, Journal of Nuclear Medicine, 52, 1240, 10.2967/jnumed.109.069609